NEW YORK (GenomeWeb News) — Waters said yesterday that weak demand and slowed spending have caused it to revise its estimated fourth-quarter 2008 and full-year financials by as much as 4 percent.

Waters, which said it will release is fourth-quarter and full 2008 earnings report Jan. 27, also said it does expect to generate free cash flow originally slated for select acquisitions, and that it will discontinue its stock-repurchase program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.